Computerized Decision Support Systems Informing Community-Acquired Pneumonia Surveillance, France, 2017–2023
Tristan Delory
1 , Josselin Le Bel
1, Raphaëlle Métras, Caroline Guerrisi, Ilona E. Suhanda, Elisabeth Bouvet, Sylvie Lariven, and Pauline Jeanmougin
Author affiliation: Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, France (T. Delory); Antibioclic Steering Committee, Paris, France (T. Delory, J. Le Bel, E. Bouvet, S. Lariven, P. Jeanmougin); Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris (T. Delory, R. Metras, C. Guerrisi, I.E. Suhanda); Université Paris Cité, Paris (J. Le Bel); Université Paris Cité et Université Sorbonne Paris Nord, INSERM, Paris (J. Le Bel); Université de Nantes, Nantes, France (P. Jeanmougin)
Main Article
Figure 1
Figure 1. Temporal pattern of prescription data requests (per 1,000 population) within the Antibioclic computerized decision support system, France, December 2017–January 2024. A) Community-acquired pneumonia; (B) sore throat with positive group A Streptococcus test; C) Lyme disease; D) overall number of requests per week. Orange bars represent the 3 national lockdowns implemented in France during the COVID-19 pandemic. Light gray bars represent winter seasons. Purple lines represent evolution in children, light blue lines in adults, dark blue lines overall population. The dashed vertical red line represents the first national alert from the Ministry of Health associated with a possible outbreak of Mycoplasma pneumoniae, including macrolide-resistant strains.
Main Article
Page created: October 07, 2024
Page updated: October 22, 2024
Page reviewed: October 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.